Displaying 1 - 9 of 9 for Cancer - Lung
  • CareSTEPS Study (H-38998)
    • The purpose of this study to evaluate a program developed for the family caregivers of advanced lung cancer patients.
  • Immune Landscape of Thoracic Malignancies (H-35782)
    • The purpose of this clinical trial is to collect information on the types of immune cells found in and around the tumor site(s).
  • Lung-MAP Study (H-35339)
    • This screening and multi-sub-study randomized phase II/III trial will establish a method for genomic screening of similar large cancer populations followed by assigning and accruing simultaneously to a multi-sub-study hybrid "Master Protocol" (S1400).
  • Malignant Pleural Mesothelioma Treatment Study (H-36460)
    • The primary objective of this study is to to determine the maximum tolerated dose of intrathoracic administration of pemetrexed when given in conjunction with cisplatin in patients with resectable MPM .
  • Mesothelioma Study (H-36952)
    • This study combines immunotherapy and surgery for the treatment of mesothelioma.
  • Mesothelioma Study (H-38140)
    • The purpose of this study is to assess whether the study drug anetumab ravtansine is more effective than a standard treatment with vinorelbine in mesothelioma patients with this type of mesothelin overexpression
  • NexTSTEPS Study (H-39002)
    • The purpose of this study is to evaluate a program that we have developed for advanced cancer patients and their family caregivers.
  • Retrospective Collection of Clinical Data on Patients Undergoing Thoracic Surgery (H-36302)
    • The purpose of this clinical trial is to generate and maintain a large, secure database of information on patients and their overall medical experience involving thoracic surgeries, including those for mesothelioma treatment.
  • TACTASOM Study (H-35425)
    • This study uses special immune system cells called tumor-associated antigen (TAA)-specific cytotoxic T lymphocytes, a new experimental therapy to treat patients with a solid tumor which has come back or has not gone away after treatment.